Solid Biosciences Shareholders Equity (Quarterly) Analysis

Solid Biosciences Inc (SLDB)

10.21 +0.67 (+7.02%) USD | NASDAQ | May 02, 16:00

10.21 0.00 (0.00%) After-Hours: 17:18

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	126.48M
September 30, 2023	144.36M
June 30, 2023	163.73M
March 31, 2023	183.79M
December 31, 2022	211.67M
September 30, 2022	143.28M
June 30, 2022	162.24M
March 31, 2022	185.51M
December 31, 2021	208.21M
September 30, 2021	223.36M
June 30, 2021	237.94M
March 31, 2021	253.00M
December 31, 2020	132.09M
September 30, 2020	22.23M

Date	Value
June 30, 2020	40.71M
March 31, 2020	56.46M
December 31, 2019	80.05M
September 30, 2019	108.52M
June 30, 2019	76.50M
March 31, 2019	99.11M
December 31, 2018	125.18M
September 30, 2018	145.07M
June 30, 2018	162.29M
March 31, 2018	178.95M
December 31, 2017	-59.26M
September 30, 2017	23.59M
December 31, 2016	-84.36M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

22.23M

Minimum

Sep 2020

253.00M

Maximum

Mar 2021

145.27M

Average

144.36M

Median

Sep 2023

Shareholders Equity (Quarterly) Benchmarks

Sarepta Therapeutics Inc	859.34M
PTC Therapeutics Inc	-893.92M
Capricor Therapeutics Inc	22.60M
Perspective Therapeutics Inc	75.18M
Electromed Inc	40.34M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly)	164.94M
Total Liabilities (Quarterly)	38.46M